Does prediabetes alone qualify for Wegovy coverage?

Usually no. Prediabetes by itself is not one of Wegovy's FDA-approved uses, so most insurers look for BMI, weight-management, heart, liver (MASH), or Medicare Bridge criteria instead. A prescription written only for prediabetes is off-label, and plans rarely cover that.

Does BMI 27 plus prediabetes qualify for Wegovy?

Sometimes. Under the Medicare GLP-1 Bridge, a BMI of 27 or higher plus ADA-defined prediabetes is a qualifying tier for eligible beneficiaries starting July 1, 2026. Under commercial insurance it depends on whether your plan counts prediabetes as a weight-related condition, and many do not.

What A1C counts as prediabetes for insurance purposes?

The American Diabetes Association defines prediabetes as an A1C of 5.7% to 6.4%, a fasting blood glucose of 100 to 125 mg/dL, or a two-hour glucose tolerance test of 140 to 199 mg/dL. For the Medicare GLP-1 Bridge, the lab value behind the diagnosis is what gets reviewed.

Does Medicare Advantage cover Wegovy for prediabetes?

A Medicare Advantage plan with prescription drug coverage can be a Bridge-eligible plan type if you meet the Medicare GLP-1 Bridge rules. The Bridge runs outside the normal Part D benefit, and prior authorization cannot be submitted before July 1, 2026. If your plan already covers Wegovy for a different approved reason, you would use that regular coverage instead.

Can I submit Wegovy under a type 2 diabetes code if I only have prediabetes?

No. Do not use a diagnosis that is not true. Prediabetes and type 2 diabetes are different conditions, and submitting a false code is insurance fraud that can harm you and your clinician.

What if my employer plan excludes weight-loss drugs?

Then BMI and prediabetes may not be enough. Ask whether Wegovy is covered for cardiovascular risk reduction or MASH instead, or compare FDA-approved cash-pay options. A benefit exclusion generally cannot be appealed away.

Is the Wegovy pill covered the same way as the injection?

Not always. CMS says all Wegovy formulations are eligible under the Medicare Bridge, but commercial coverage and pharmacy rules can treat the pill and injection differently by plan. The pill is FDA-approved only for adults for weight and heart-risk uses, while the injection also covers ages 12 and older and MASH. Check your specific formulary.

How much is Wegovy without insurance?

As of June 2026, the Wegovy pill starts at $149 a month and the pen is $349 a month at standard pricing, with a $199 intro offer for new patients on starting doses, and Wegovy HD is $399. Real-world Wegovy cash prices land between $149 and $399 a month before separate care fees. Terms change often, so confirm before you buy.

Should I use Ro or Sesame for Wegovy?

Use Ro first if your main question is coverage or prior authorization — it has a free coverage checker and an insurance team that handles paperwork. Use Sesame as a strong second if you want provider choice, Costco-linked pricing, or prefer to pay cash for branded Wegovy.

What should I do first after a Wegovy denial?

Get the exact denial reason in writing. Then figure out whether the problem is missing documentation, the wrong route, an excluded benefit, or non-formulary status — because each one has a completely different fix.

Last verified: June 10, 2026The RX Index Editorial TeamDisclosure

Does Insurance Cover Wegovy for Prediabetes?

Usually not for prediabetes by itself — but that “no” is rarely the whole story. Here are 5 real routes that can get Wegovy covered, including the new Medicare GLP-1 Bridge that names prediabetes as a qualifier.

Disclosure: The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. We may earn a commission if you use some provider links on this page — it never changes one word of the coverage facts below. This guide is general information, not medical advice.

Bottom line up front: Prediabetes is not an FDA-approved use for Wegovy, so when a prescription is written only because your blood sugar is “almost diabetes,” most commercial insurance plans deny it. Coverage becomes realistic when the request fits a different approved route — like obesity or overweight criteria, heart disease, liver disease (MASH), or the new Medicare GLP-1 Bridge. A denial often means the wrong route was submitted, not that no route exists.

Your situation at a glance

Your situation	Does Wegovy coverage usually happen?	Your best next step
Prediabetes only (normal weight)	Usually no	Check if any other route fits; talk to your doctor about first-line options
BMI 30+ and your plan covers weight-loss drugs	Often possible	Submit a prior authorization under the weight-management rules
BMI 27–29.9 + prediabetes, commercial plan	Plan-specific	Ask if your plan counts prediabetes as a weight-related condition
Medicare Part D + BMI 27+ + prediabetes	Yes, if you meet all Bridge rules	Prepare for the Medicare GLP-1 Bridge (starts July 1, 2026)
Your plan excludes weight-loss drugs	Usually no	Check a heart or liver route, the Medicare Bridge, or cash-pay

You don’t have to guess whether your plan covers Wegovy.

Ro’s free GLP-1 Insurance Coverage Checker runs your actual plan and shows whether Wegovy is listed, whether prior authorization is required, and your estimated cost — before you spend a dollar. The free checker gives you a coverage report; it doesn’t submit a prior authorization, write a prescription, or guarantee approval.

Check my Wegovy coverage free → (Ro)

Disclosure: The RX Index may earn a commission if you start care through Ro, at no extra cost to you.

Does insurance cover Wegovy for prediabetes? The short answer

Insurance usually won’t cover Wegovy when prediabetes is the only reason for the prescription, because prediabetes isn’t an FDA-approved use. Coverage becomes realistic when the request fits a different approved route — like obesity or overweight criteria, heart disease, liver disease (MASH), or the new Medicare GLP-1 Bridge. A denial often means the wrong route was submitted, not that no route exists.

The reason this question trips people up is that the word “prediabetes” is doing three different jobs at once:

Prediabetes as a diagnosis on your chart. On its own, it’s a weak argument for commercial Wegovy coverage.
Prediabetes as a possible “comorbidity.” Some plans approve Wegovy at a BMI of 27 or higher if you also have a weight-related condition. Whether prediabetes counts depends on the plan — and many don’t list it.
Prediabetes as a Medicare Bridge qualifier. Starting July 1, 2026, the Medicare GLP-1 Bridge specifically lists prediabetes (paired with a BMI of 27+) as a way to qualify. Here, prediabetes is genuinely powerful.

In Wegovy patient communities, the story you see again and again isn’t “it’s impossible” — it’s “we got denied, then learned the request was filed under prediabetes instead of the route our plan actually covers.” Knowing that difference is most of the battle.

Is Wegovy FDA-approved for prediabetes?

No. Wegovy is not FDA-approved as a treatment for prediabetes. Its approved uses are long-term weight management, lowering the risk of heart attack and stroke in adults with heart disease and excess weight, and — for the injection only — a liver condition called MASH. A prescription written for prediabetes alone is “off-label,” and insurance is not required to cover off-label uses.

One detail that matters a lot: the Wegovy pill and the injection are not approved for the exact same things.

Wegovy approved use	Which form	Helps a prediabetes coverage request?	Why it matters for insurance
Chronic weight management (obesity, or overweight + a weight-related condition)	Injection (adults and kids 12+) and tablet/pill (adults only)	Indirectly — it's about your weight, not your blood sugar	This is the main route Wegovy gets covered, if you meet the BMI rules
Cardiovascular risk reduction (established heart disease + obesity/overweight)	Injection and tablet (adults)	No — heart disease is the trigger, not prediabetes	A separate route that can work even when weight-loss coverage is excluded
MASH with moderate-to-advanced liver fibrosis (F2–F3, no cirrhosis)	Injection only (adults)	No — unrelated to prediabetes	Another non-weight route some plans cover
Prediabetes	Not an approved use	This is the gap	Why a prediabetes-only request usually gets denied

What “off-label” actually means for you

Off-label means a doctor prescribes a medication for something other than its FDA-approved use. This is legal and common. The catch is simple: insurance does not have to pay for off-label prescriptions. Some plans will, with extra paperwork. Most won’t, especially for a drug as expensive as Wegovy. So if your doctor’s office sends in a Wegovy request and lists “prediabetes” as the reason, your plan sees a use it doesn’t cover and denies it. That’s not a judgment on whether you’d benefit. It’s a paperwork mismatch.

One safety note before we go furtherWegovy isn’t right for everyone, and it carries a boxed warning about a risk of thyroid C-cell tumors seen in animal studies. It should not be used by people with a personal or family history of medullary thyroid cancer or a condition called MEN 2. Whether Wegovy is appropriate for you is a decision for you and a licensed clinician, not an insurance form.

The 5 real Wegovy coverage routes when you have prediabetes

The five real approval routes are commercial weight-management coverage (by BMI), BMI 27+ with a plan-recognized condition, a cardiovascular route, a MASH (liver) route, and the Medicare GLP-1 Bridge. The right one depends on your insurance type, your BMI, your medical history, and whether your plan excludes weight-loss drugs at all. Prediabetes by itself only carries real weight in the Medicare Bridge route.

The Wegovy Prediabetes Coverage Route Matrix

Coverage route	What has to be true	Does prediabetes help?	Our read on your odds	Source
Prediabetes alone	Wegovy requested only because A1C is in the prediabetes range	Usually no	Low	FDA label
Commercial plan, BMI 30+	Adult meets the obesity BMI cutoff and the plan covers weight-loss drugs	Not required	Medium–high if the benefit exists	Insurer PA criteria
Commercial plan, BMI 27–29.9 + condition	Overweight BMI plus a plan-recognized weight-related condition	Sometimes — plan-specific	Medium if prediabetes is accepted; lower if not	Insurer PA criteria
Plan excludes weight-loss drugs	Your employer or plan carved out anti-obesity medications	Usually no	Low unless another route applies	Insurer benefit docs / KFF
Established heart disease + excess weight	Prior heart attack, stroke, or symptomatic PAD, plus BMI criteria	Not the key factor	Medium–high if the plan covers this route	FDA label
MASH (liver) route	Wegovy injection for noncirrhotic MASH with moderate-to-advanced fibrosis (F2–F3)	Not the key factor	Plan-specific	FDA label
Medicare GLP-1 Bridge (from July 1, 2026)	Part D, age 18+, weight loss with lifestyle changes, and BMI tier met	Yes — BMI 27+ with prediabetes is a qualifying tier	High if you meet all Bridge rules	CMS
Medicaid	Your state covers obesity drugs, or another covered use applies	State-specific	Varies a lot by state	KFF / state Medicaid
ACA Marketplace plan	A rare Marketplace plan that includes anti-obesity coverage	Sometimes, but uncommon	Low (~1% of plans cover Wegovy)	KFF
Cash-pay backup	Insurance denies or excludes Wegovy	Not relevant	High if it's affordable for you	NovoCare / Ro / Sesame

“Our read on your odds” is The RX Index’s interpretation of public coverage criteria — not a guarantee. Your actual plan controls the outcome.

Find yourself in one line

If this is you	Start here
Commercial insurance, BMI 30+	Weight-management prior authorization
Commercial insurance, BMI 27–29.9, prediabetes	Ask if prediabetes counts as a condition
Medicare Part D, BMI 27+, prediabetes	The Medicare GLP-1 Bridge
Prior heart attack, stroke, or PAD	The cardiovascular route
MASH with documented liver fibrosis	The MASH route
Already denied, not sure why	Get the denial reason, then the appeal checklist

Find the route to check first → free 60-second quiz

Your insurance type, BMI, and denial status — matched to the route your plan can actually say yes to

What counts as prediabetes for coverage purposes?

For any coverage conversation, prediabetes should be documented with real lab numbers, not described casually. The American Diabetes Association defines prediabetes as an A1C of 5.7%–6.4%, a fasting blood glucose of 100–125 mg/dL, or a two-hour glucose tolerance test of 140–199 mg/dL. Those exact numbers matter, especially for the Medicare Bridge.

Test	Prediabetes range	How to use it in a coverage request
A1C	5.7% – 6.4%	Documents ADA-defined prediabetes for the Medicare Bridge (Tier 3); ask a commercial plan if it counts as a condition
Fasting blood glucose	100 – 125 mg/dL	Attach the lab value itself, not just the word "prediabetes"
2-hour glucose tolerance test (OGTT)	140 – 199 mg/dL	Any one of these three can establish prediabetes

Why this is worth getting right: the Medicare GLP-1 Bridge specifically points to “prediabetes, as defined by American Diabetes Association guidelines” as a qualifying condition when paired with a BMI of 27 or higher. So the lab number isn’t a detail — it’s the key that opens that door. For commercial plans, the lab value still helps your case, but it doesn’t guarantee anything, because many plans don’t list prediabetes as a covered condition at all.

What BMI or diagnosis usually qualifies Wegovy for insurance?

Most commercial prior-authorization rules follow a pattern: a BMI of 30 or higher, or a BMI of 27 or higher with a plan-recognized weight-related condition, plus proof you’ve tried lifestyle changes. But the plan’s benefit design overrides everything — if your employer or plan excludes weight-loss drugs, meeting the BMI cutoff still may not get you covered.

Key PA terms you’ll encounter

Prior authorization (PA)

Approval your insurer requires before it will pay for a drug. Your doctor's office submits documentation showing you meet the plan's rules.

Formulary

The plan's list of covered drugs. Being on the formulary doesn't mean automatic coverage.

Step therapy

The plan requires you to try a cheaper option first before it'll cover Wegovy.

The common commercial pattern

Across the insurer criteria reviewed — including public Aetna and UnitedHealthcare rules — Wegovy prior authorization usually looks like this:

A BMI of 30 or higher often meets the obesity criteria on its own.
A BMI of 27 to 29.9 usually needs a recognized weight-related condition.
Most plans want documentation of lifestyle changes — a reduced-calorie diet and physical activity.
Prior authorization is almost always required, and so is renewal down the road.

The conditions insurers commonly accept are high blood pressure, type 2 diabetes, high cholesterol, sleep apnea, and heart disease. Even Novo Nordisk’s own coverage page notes that most plans require prior authorization and that a request can take up to 10 business days.

Does prediabetes count as a “condition”? Sometimes — don’t assume

Prediabetes is often not on the list of accepted weight-related conditions for the BMI 27 route. The conditions insurers usually name are high blood pressure, high cholesterol, type 2 diabetes, sleep apnea, heart disease. Prediabetes sits in a gray zone, and it varies by plan.

The exact question to ask your insurer:

“Does my plan count ADA-defined prediabetes as a weight-related comorbidity for Wegovy prior authorization?”

What if your BMI is lower now because you already lost weight?

Some plans look at your BMI at the time you started therapy, not today’s number. Many require ongoing proof of progress — a common renewal rule is showing at least 5% weight loss. If you’ve lost weight, make sure your records reflect your starting point, not just where you are now.

Does Medicare cover Wegovy for prediabetes?

Historically no — Medicare is barred by federal law from covering drugs used for weight loss. But starting July 1, 2026, the temporary Medicare GLP-1 Bridge lets eligible Part D members get Wegovy for weight loss at a $50 monthly drug copay, and one qualifying path is a BMI of 27 or higher with ADA-defined prediabetes. This is the single biggest exception to the “Medicare won’t pay” rule, and it’s the one route where prediabetes genuinely works in your favor.

We have a full walkthrough on our Medicare GLP-1 Bridge guide. Here’s what matters specifically for prediabetes.

The Medicare GLP-1 Bridge, in plain English

The Medicare GLP-1 Bridge is a short-term CMS program that runs from July 1, 2026 through December 31, 2027. It exists because regular Medicare Part D still can’t cover weight-loss drugs — Congress would have to change the law for that. The Bridge is a workaround that delivers coverage outside the normal Part D system.

Who qualifies through prediabetes (Tier 3)

CMS set three eligibility tiers. Prediabetes lives in the third one:

Tier 1: BMI ≥ 35

No other condition needed

Tier 2: BMI ≥ 30

Heart failure, uncontrolled high blood pressure, or chronic kidney disease (stage 3a+)

Tier 3: BMI ≥ 27

Prediabetes (ADA-defined), prior heart attack, prior stroke, or symptomatic peripheral artery disease

So if you’re on Medicare Part D, have a BMI of 27 or more, and have documented prediabetes, you have a real, named path to $50-a-month Wegovy starting in July 2026. Your clinical criteria are judged based on when you first started GLP-1 therapy — so if you started earlier at a higher BMI, your prescriber can attest to that starting point.

What it costs

The copay is a flat $50 for a monthly supply of the drug — and no coupons or discount cards can lower it further. Behind the scenes, participating drugmakers provide the medicine at a net price of $245 a month; you pay the $50.

Read this carefully — it’s a real catchThe Bridge runs outside your normal Part D benefit. That means the $50 you pay does NOT count toward your Part D deductible or your $2,100 annual out-of-pocket cap, and the usual low-income subsidy protections don’t apply. For most people the $50 is a steal compared to cash prices. For the most financially stretched beneficiaries, a flat $50 every month can still sting.

Which Wegovy forms are covered

The Bridge covers all formulations of Wegovy — both the injection and the oral pill — plus the Foundayo pill and the Zepbound KwikPen (the KwikPen version only; Zepbound vials and single-dose pens aren’t included).

What Medicare readers should NOT do

Don’t assume regular Part D covers Wegovy for prediabetes. It doesn’t. Only the Bridge route does, and only for weight loss.
Don’t try to submit early. CMS has confirmed that Bridge prior-authorization requests will not be accepted or processed before July 1, 2026.
Don’t confuse the Bridge with diabetes coverage. If you actually have type 2 diabetes, semaglutide as Ozempic may already be covered through your normal Part D plan — a different, often easier path.

On Medicare? Your answer changes on July 1, 2026 — get the timing right.

The Bridge runs through your own prescriber and a CMS processor, not a telehealth signup. The smartest move now is to make sure your prediabetes and BMI are documented and to know the exact PA steps before the window opens.

See the full Medicare GLP-1 Bridge guide →

What if my Wegovy prior authorization was denied for prediabetes?

A denial usually isn’t the end. The first move is to get the exact denial reason in writing — because the fix is completely different depending on whether the problem was a benefit exclusion, missing documentation, or the wrong route.

Denial reason decision tree

What the denial says	What it usually means	Your next move
Weight-loss drugs excluded	Your plan doesn't cover Wegovy for weight at all	Check a heart or liver route, or go cash-pay
Prediabetes not accepted	Your plan doesn't count prediabetes as a covered condition	Submit a different true condition if you have one, or use the BMI 30+ route
BMI missing	The PA didn't include your BMI or starting weight	Resubmit with chart documentation
Lifestyle program missing	The plan requires proof of a weight-management effort	Add physician notes, nutrition records, or program history
Wrong drug route	Wegovy was filed under "prediabetes" instead of weight/heart/liver	Resubmit under the correct true route
Continuation denied	The plan needs proof you're responding	Submit your starting weight and current progress

A call script that actually gets answers

Pick up the phone and read this, almost word for word:

“I’m calling about a denied Wegovy prior authorization. Can you tell me the specific denial reason? Is Wegovy excluded entirely, or does it just require meeting criteria? Does my plan count prediabetes as a weight-related condition? And what documents do you need for an appeal?”

Write down the answers. Those four answers tell you exactly which route is left and what to gather.

The one thing we will never tell you to doDo not ask a clinician to use a diagnosis code that isn’t true — for example, billing you as a type 2 diabetic when you have prediabetes. That’s insurance fraud, it puts your doctor’s license at risk, and it can leave you with a permanent inaccurate medical record. The goal is never to trick your insurer. It’s to submit the correct, truthful route your plan already recognizes.

Turn my denial into an action plan → free, no email

What to gather, what to say, and whether an appeal is even worth it

What documents help a Wegovy prior authorization or appeal?

The strongest Wegovy PA or appeal usually includes your starting BMI, current weight, prediabetes labs, any other qualifying conditions, your lifestyle-change history, and the denial letter itself. Incomplete documentation is one of the most common reasons a request fails even when you “should” qualify.

Here’s the checklist your doctor’s office will thank you for.

✓Your baseline BMI at the time treatment started

✓Your current BMI and weight

✓An A1C, fasting glucose, or OGTT result showing prediabetes

✓Documentation of any other relevant conditions — blood pressure, cholesterol, sleep apnea, kidney disease, heart disease, or MASH

✓Your medication history

✓A lifestyle-modification plan (diet and activity)

✓Any weight-management program history

✓Your denial letter, if you have one

✓Your plan's formulary or benefit language

✓A letter of medical necessity from your clinician, if appropriate

Screenshot these before you appeal: your plan’s formulary page showing Wegovy’s status, the PA criteria if you can find them, the denial reason, and any plan message about weight-loss exclusions. Paper trails win appeals.

Can I appeal a Wegovy denial for prediabetes?

Yes, but the appeal has to target the actual denial reason — not just repeat that you have prediabetes. The strongest appeals argue the correct covered route with documentation to back it. Appeals that simply restate the same prediabetes request tend to fail the same way.

When an appeal is worth your time

The PA was missing required documents (BMI, labs, lifestyle history)
Your plan does accept prediabetes but the records were incomplete
Your starting BMI or weight was left off
You have another true qualifying condition that wasn’t included
You qualify through a heart or liver route
The denial was administrative, not a hard exclusion

When an appeal probably won’t work

Your plan excludes anti-obesity drugs entirely
Prediabetes is your only diagnosis and no covered route applies
The only path forward would require an untrue diagnosis
The lifestyle documentation the plan requires doesn’t exist yet

What goes in a strong appeal letter

The denial reason, the plan’s own criteria, the route you’re requesting, your baseline BMI, your current BMI, your prediabetes lab value, any other conditions, your lifestyle-program history, your clinician’s rationale, and a clear statement of what you want the plan to do. Specific beats emotional, every time.

Get my personalized next step → free, 60 seconds

Whether to appeal, switch routes, or go straight to a cash-pay path that fits your situation

What does Wegovy cost if insurance doesn’t cover it?

If insurance says no, cash-pay Wegovy is far cheaper than the old $1,350-a-month list price, but it’s still a real expense. As of June 2026, the Wegovy pill starts at $149 a month, the pen is $349 a month at standard pricing (with a $199 intro offer for new patients), and the higher-dose Wegovy HD is $399. Real-world Wegovy cash prices land between $149 and $399 a month before any separate telehealth or program fees.

Verified June 10, 2026, against NovoCare and Wegovy.com. Pricing changes fast — and some intro offers expire June 30, 2026 — so confirm current prices before you commit.

Route	Wegovy form	Published price (June 2026)	The catch
NovoCare (direct from maker)	Wegovy pill	$149/mo for 1.5 mg and 4 mg; $299/mo for 9 mg and 25 mg	The 4 mg offer runs through Aug. 31, 2026, then $199/mo; one month = one bottle of 30 tablets
NovoCare	Wegovy pen	$199/mo for 0.25 mg and 0.5 mg (first 2 fills, through June 30, 2026), then $349/mo	One month = one box of 4 pens
NovoCare	Wegovy HD (7.2 mg)	$399/mo	The highest dose
Manufacturer savings card	Wegovy pill/pen	As little as $25/mo	Only if you have commercial insurance and coverage; max savings $100/mo; government beneficiaries excluded
Ro	Wegovy pill	From $149/mo	Separate membership fee applies
Ro	Wegovy injection	$199–$399/mo	Medication billed separately from membership
Sesame / Costco	Wegovy pill	From ~$149/mo	Care/subscription cost is separate; verify current price
Sesame / Costco	Wegovy pen	~$199/mo first two months, then ~$349/mo	Costco-linked route; active prescription required

“Cash-pay” doesn’t mean “no doctor”

Wegovy is prescription-only no matter how you pay. A licensed clinician still has to decide it’s appropriate for you. “Cash-pay” just means your insurance isn’t footing the bill for the drug — and the medication cost and any telehealth or program fee may be billed separately. Read the fine print so the monthly total isn’t a surprise.

If insurance says no, compare the FDA-approved cash routes before you give up.

Ro is the most useful starting point: it pairs FDA-approved Wegovy at manufacturer-matched cash prices with a free coverage checker and an insurance team that fights for approval. If you’d rather shop providers and want Costco-linked pricing, Sesame is a strong second.

See current Wegovy pricing with Ro →Compare Sesame’s Wegovy options →

Disclosure: The RX Index may earn a commission if you start care through Ro or Sesame, at no extra cost to you.

Should I start with Ro, Sesame, my doctor, or my insurance company?

Start with the route that matches your problem. If you don’t know whether Wegovy is covered, start with a free coverage check. If you’ve already been denied, start with the denial reason. If your plan excludes weight-loss drugs, compare cash-pay options. If you’re on Medicare with prediabetes, prepare for the Bridge.

Your situation	Best first move	Why
You don't know if Wegovy is covered	Ro's free coverage checker	It shows coverage and whether PA is required
Your doctor submitted and you were denied	Ask your insurer for the exact denial reason	You need the reason before you can fix it
Medicare Part D, BMI 27+, prediabetes	The Medicare GLP-1 Bridge checklist	The route is different starting July 1, 2026
Your plan excludes weight-loss drugs	Check a heart/liver route, then cash-pay	BMI criteria may not matter if it's excluded
You want provider choice or Costco pricing	Sesame Care	Good for self-pay branded Wegovy shoppers
You're not sure which GLP-1 path fits you	Our free matching quiz	Built for when you're still deciding

Why we point most people to Ro first here

For this search — someone anxious about Wegovy coverage, maybe already denied — Ro fits the job better than any other option for one concrete reason: it’s built around the insurance problem you’re actually having. Ro’s free GLP-1 Insurance Coverage Checker shows whether your plan lists Wegovy and whether prior authorization is required, and if you enroll, an insurance concierge submits the PA, follows up on denials, and appeals on your behalf.

Here’s the honest catch. Ro is not the cheapest way to get the Wegovy molecule. If you already have a doctor who prescribes for you and you qualify for manufacturer-direct pricing through NovoCare, you can get the same FDA-approved Wegovy at the same cash price without paying Ro’s membership fee. So if all you want is the cheapest possible medication and you’ve already got a prescriber, skip the membership and go direct to NovoCare — we’d rather tell you that than have you overpay.

But that’s exactly why the membership makes sense for the people it makes sense for. You’re not paying Ro for the molecule. You’re paying for the system around it: the insurance concierge that handles the prior- authorization paperwork most people dread, the licensed provider who reviews your labs, and the coaching. If you have commercial insurance and you’re tired of fighting the PA alone, that system is the value.

When Sesame is the better call

Sesame is the stronger pick if you’ve already accepted you’ll pay cash for branded Wegovy and you want provider choice or Costco-linked pricing. Sesame lists cash-pay GLP-1 medications from around $149 a month, with medication costs separate from its program fee. Confirm the current price before you enroll.

Check my Wegovy coverage free with Ro →

What if my plan flat-out excludes Wegovy for weight loss?

If your plan excludes weight-loss medications, prediabetes will almost never override that exclusion. Your remaining options are a covered non-weight use (like heart-risk reduction or MASH), the Medicare GLP-1 Bridge if you qualify, a state Medicaid route, or FDA-approved cash-pay Wegovy. A benefit exclusion is a wall, not a hurdle — but there are usually ways around the wall.

Exactly what to ask your insurer

“Is Wegovy excluded entirely, or only excluded for weight loss?”
“Is Wegovy covered for cardiovascular risk reduction?”
“Is the Wegovy injection covered for MASH?”
“Does my plan have a PA pathway for a BMI of 30 or higher?”
“Does my plan count prediabetes as a weight-related condition?”
“Can you send me the written criteria?”

A reality check on Marketplace and Medicaid

If you’re on an ACA Marketplace plan, brace yourself: KFF found that Wegovy was covered by just 1% of Marketplace prescription drug plans in 2024, versus 82% for Ozempic (which is approved for diabetes, not weight). The trend is clear. Medicaid is entirely state-by-state: KFF reports that 13 state Medicaid programs covered GLP-1s for obesity as of January 2026, and several states have been cutting coverage, not adding it (California ended its Medicaid weight-loss coverage at the start of 2026). Check your specific state and plan before assuming anything.

Mistakes to avoid when trying to get Wegovy covered

The biggest mistakes are submitting a misleading diagnosis code, assuming Ozempic is an automatic substitute, and confusing FDA-approved Wegovy with compounded semaglutide. The safe path is truthful documentation under a route your plan actually recognizes.

✗ Don't use a false diagnosis code

Don't ask for a type 2 diabetes code unless you actually have type 2 diabetes. Prediabetes and diabetes are different diagnoses, and faking one is fraud.

✗ Don't assume Ozempic is a Wegovy stand-in

Ozempic and Wegovy both contain semaglutide, and Ozempic is often covered more easily — but only because it's FDA-approved for type 2 diabetes, which you don't have if you're prediabetic. They're not interchangeable on a coverage form.

✗ Don't confuse Wegovy with compounded semaglutide

Compounded semaglutide is not FDA-approved Wegovy. The FDA does not review compounded drugs for safety, effectiveness, or quality before they're sold. This page is about FDA-approved Wegovy.

See our full Ozempic vs. Wegovy comparison if you want the full breakdown of why these two aren’t interchangeable on a coverage form.

Still not sure which GLP-1 program is right for you?

You’ve got the full coverage map now — the five routes, the Medicare Bridge, the denial playbook, and the real prices. If you still aren’t sure which path fits your insurance, your BMI, and your situation, we built something for exactly that moment.

Get my personalized GLP-1 action plan → free, 60 seconds

The route to check first, the documents to gather, and where to start. No pressure, no purchase required.

Frequently asked questions

Does prediabetes alone qualify for Wegovy coverage?: Usually no. Prediabetes by itself is not one of Wegovy's FDA-approved uses, so most insurers look for BMI, weight-management, heart, liver (MASH), or Medicare Bridge criteria instead. A prescription written only for prediabetes is off-label, and plans rarely cover that.
Does BMI 27 plus prediabetes qualify for Wegovy?: Sometimes. Under the Medicare GLP-1 Bridge, a BMI of 27 or higher plus ADA-defined prediabetes is a qualifying tier for eligible beneficiaries starting July 1, 2026. Under commercial insurance it depends on whether your plan counts prediabetes as a weight-related condition, and many do not.
What A1C counts as prediabetes for insurance purposes?: The American Diabetes Association defines prediabetes as an A1C of 5.7% to 6.4%, a fasting blood glucose of 100 to 125 mg/dL, or a two-hour glucose tolerance test of 140 to 199 mg/dL. For the Medicare GLP-1 Bridge, the lab value behind the diagnosis is what gets reviewed.
Does Medicare cover Wegovy for prediabetes?: Starting July 1, 2026, eligible Medicare Part D members may qualify through the Medicare GLP-1 Bridge if they meet all CMS rules, including a BMI of 27 or higher with prediabetes, for a $50 monthly drug copay. Before the Bridge, regular Part D does not cover GLP-1s for prediabetes or weight loss.
Does Medicare Advantage cover Wegovy for prediabetes?: A Medicare Advantage plan with prescription drug coverage can be a Bridge-eligible plan type if you meet the Medicare GLP-1 Bridge rules. The Bridge runs outside the normal Part D benefit, and prior authorization cannot be submitted before July 1, 2026. If your plan already covers Wegovy for a different approved reason, you would use that regular coverage instead.
Can I submit Wegovy under a type 2 diabetes code if I only have prediabetes?: No. Do not use a diagnosis that is not true. Prediabetes and type 2 diabetes are different conditions, and submitting a false code is insurance fraud that can harm you and your clinician.
What if my employer plan excludes weight-loss drugs?: Then BMI and prediabetes may not be enough. Ask whether Wegovy is covered for cardiovascular risk reduction or MASH instead, or compare FDA-approved cash-pay options. A benefit exclusion generally cannot be appealed away.
Is the Wegovy pill covered the same way as the injection?: Not always. CMS says all Wegovy formulations are eligible under the Medicare Bridge, but commercial coverage and pharmacy rules can treat the pill and injection differently by plan. The pill is FDA-approved only for adults for weight and heart-risk uses, while the injection also covers ages 12 and older and MASH. Check your specific formulary.
How much is Wegovy without insurance?: As of June 2026, the Wegovy pill starts at $149 a month and the pen is $349 a month at standard pricing, with a $199 intro offer for new patients on starting doses, and Wegovy HD is $399. Real-world Wegovy cash prices land between $149 and $399 a month before separate care fees. Terms change often, so confirm before you buy.
Should I use Ro or Sesame for Wegovy?: Use Ro first if your main question is coverage or prior authorization — it has a free coverage checker and an insurance team that handles paperwork. Use Sesame as a strong second if you want provider choice, Costco-linked pricing, or prefer to pay cash for branded Wegovy.
What should I do first after a Wegovy denial?: Get the exact denial reason in writing. Then figure out whether the problem is missing documentation, the wrong route, an excluded benefit, or non-formulary status — because each one has a completely different fix.

Sources

U.S. Food & Drug Administration / Novo Nordisk — Wegovy prescribing information and approval record (weight management 2021; adolescents 2022; cardiovascular risk 2024; MASH August 2025; oral Wegovy December 2025)
Centers for Medicare & Medicaid Services (CMS) — Medicare GLP-1 Bridge: Information for Beneficiaries; Information for Providers
American Diabetes Association — Prediabetes diagnostic criteria; Standards of Care in Diabetes 2026, prevention of type 2 diabetes
KFF — “Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans”; “Medicaid Coverage of and Spending on GLP-1s”
NovoCare / Wegovy.com — Wegovy cost and coverage pages
Public insurer prior-authorization criteria, including Aetna and UnitedHealthcare

Medical disclaimer: This guide is for general information only and is not medical advice. Wegovy is a prescription medication with risks and contraindications; only a licensed clinician can decide if it’s right for you. Coverage rules, program terms, and prices change and vary by plan and location — verify current details with your insurer, your prescriber, and the provider before acting.

Affiliate disclosure: The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. We may earn a commission if you start care through some of the links on this page, at no additional cost to you. This never changes the facts we report or the route we recommend.

Check Wegovy coverage free →

Related guides